Treatment options available for breast cancer patients include surgery, combination chemotherapy, radiation therapy, hormone therapy (for estrogen or progesterone receptor positive cases), anti-HER2 antibodies (e.g., trastuzumab) and PARP inhibitors (for tumors with germline mutations in the BRCA gene). Here, ERBB2 is linked to breast carcinoma.